K
Karla V. Ballman
Researcher at Cornell University
Publications - 390
Citations - 34158
Karla V. Ballman is an academic researcher from Cornell University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 78, co-authored 353 publications receiving 29127 citations. Previous affiliations of Karla V. Ballman include University of South Florida & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease
Cynthia S. Crowson,Paulo Nicola,Hilal Maradit Kremers,W. Michael O'Fallon,Terry M. Therneau,Steven J. Jacobsen,Véronique L. Roger,Karla V. Ballman,Sherine E. Gabriel +8 more
TL;DR: The excess risk of HF among RA patients is not explained by an increased frequency or effect of CV risk factors and IHD, and ischemic heart disease and alcohol abuse.
Journal ArticleDOI
Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.
Ronald P. DeMatteo,Karla V. Ballman,Cristina R. Antonescu,Christopher L. Corless,Violetta Kolesnikova,Margaret von Mehren,Martin D. McCarter,Jeffrey A. Norton,Robert G. Maki,Peter W.T. Pisters,George D. Demetri,Murray F. Brennan,Kouros Owzar +12 more
TL;DR: Adjuvant imatinib in patients with primary GIST who are at high risk of recurrence prolongs OS compared with that of historical controls, and Optimal duration of adjuvant therapy remains undefined.
Journal ArticleDOI
Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study.
Nadia N. Laack,Paul D. Brown,Robert J. Ivnik,Alfred Furth,Karla V. Ballman,Julie E. Hammack,Robert M. Arusell,Edward G. Shaw,Jan C. Buckner +8 more
TL;DR: Cognitive function was stable after RT in these patients evaluated prospectively during 3 years of follow-up, and light improvements in some cognitive areas are consistent with practice effects attributable to increased familiarity with test procedures and content.
Journal ArticleDOI
Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence
Martin D. McCarter,Cristina R. Antonescu,Karla V. Ballman,Robert G. Maki,Peter W.T. Pisters,George D. Demetri,Charles D. Blanke,Margaret von Mehren,Murray F. Brennan,Linda M. McCall,David M. Ota,Ronald P. DeMatteo +11 more
TL;DR: The difference in recurrence-free survival with or without imatinib therapy in those undergoing an R1 vs R0 resection was not statistically significant at a median follow-up of 4 years and the risk of disease recurrence in R1 patients was driven largely by the presence of tumor rupture.
Journal ArticleDOI
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: Results of the American College of Surgeons Oncology Group Z0060 trial
Bryan F. Meyers,Robert J. Downey,Paul A. Decker,Robert J. Keenan,Barry A. Siegel,Robert J. Cerfolio,Rodney J. Landreneau,Carolyn E. Reed,Dennis M. Balfe,Farrokh Dehdashti,Karla V. Ballman,Valerie W. Rusch,Joe B. Putnam +12 more
TL;DR: Although 22% of eligible patients did not undergo esophagectomy, FDG-PET after standard clinical staging for esophageal carcinoma identified confirmed M1b disease in at least 4.8% of patients before resection.